4//SEC Filing
Brandt Kevin D 4
Accession 0001235802-23-000112
CIK 0001453593other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:42 PM ET
Size
5.7 KB
Accession
0001235802-23-000112
Insider Transaction Report
Form 4
Brandt Kevin D
VP & Chief Commercial Officer
Transactions
- Purchase
Common Stock
2023-11-17$1.20/sh+41,670$49,837→ 815,860 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.228, inclusive. The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]Includes 120,499 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
Related Parties
1- filerCIK 0001692661
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:42 PM ET
- Size
- 5.7 KB